Cargando…

Assessment of expression levels of leptin and leptin receptor as potential biomarkers for risk of prostate cancer development and aggressiveness

BACKGROUND: Prostate cancer (PCa) is one of the most frequently diagnosed cancers worldwide. Despite the growing evidence associating obesity and adipokines, particularly leptin and its receptors, with cancer development and progression, it is still a debatable matter in PCa. OBJECTIVES: We aimed to...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kamel, Hala Fawzy Mohamed, Nassir, Anmar M., Al refai, Abeer A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Cancer Prevention
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7402836/ https://www.ncbi.nlm.nih.gov/pubmed/32573960 http://dx.doi.org/10.1002/cam4.3082

Ejemplares similares

Serum leptin, C‐reactive protein, and cancer mortality in the NHANES III
por: Wulaningsih, Wahyu, et al.
Publicado: (2015)

Adiposity and breast, endometrial, and colorectal cancer risk in postmenopausal women: Quantification of the mediating effects of leptin, C‐reactive protein, fasting insulin, and estradiol
por: Dashti, S. Ghazaleh, et al.
Publicado: (2022)

Prostate cancer in Pennsylvania: The role of older age at diagnosis, aggressiveness, and environmental risk factors on treatment and mortality using data from the Pennsylvania Cancer Registry
por: Bluethmann, Shirley M., et al.
Publicado: (2020)

Leptin levels and leptin receptor polymorphism frequency in healthy populations
por: Ragin, Camille C, et al.
Publicado: (2009)

Vitamin D deficiency and supplementation in patients with aggressive B‐cell lymphomas treated with immunochemotherapy
por: Hohaus, Stefan, et al.
Publicado: (2017)

Identification of potential biomarkers from microarray experiments using multiple criteria optimization
por: Sánchez-Peña, Matilde L, et al.
Publicado: (2013)

Association between lactate dehydrogenase levels and oncologic outcomes in metastatic prostate cancer: A meta‐analysis
por: Li, Fan, et al.
Publicado: (2020)

Assessment of different mathematical models for diffusion‐weighted imaging as quantitative biomarkers for differentiating benign from malignant solid hepatic lesions
por: Hu, Yao, et al.
Publicado: (2018)

Association of serum soluble leptin receptor and leptin levels with breast cancer
por: Mohammadzadeh, Ghorban, et al.
Publicado: (2014)

Leptin and leptin receptor expression as biomarkers for breast cancer: a retrospective study
por: Wang, Yan, et al.
Publicado: (2023)

Explication of the roles of prostate health index (PHI) and urokinase plasminogen activator (uPA) as diagnostic and predictor tools for prostate cancer in equivocal PSA range of 4–10 ng/mL
por: Nassir, Anmar M., et al.
Publicado: (2020)

Part I: cancer in Sudan—burden, distribution, and trends breast, gynecological, and prostate cancers
por: Elamin, Amany, et al.
Publicado: (2015)

Both serum 25-hydroxyvitamin D and calcium levels may increase the risk of incident prostate cancer in Caribbean men of African ancestry
por: Jackson, Maria D, et al.
Publicado: (2015)

In silico DNA methylation analysis identifies potential prognostic biomarkers in type 2 papillary renal cell carcinoma
por: Yang, Man, et al.
Publicado: (2019)

On the Molecular Evolution of Leptin, Leptin Receptor, and Endospanin
por: Londraville, Richard Lyle, et al.
Publicado: (2017)

Soluble endothelial protein C receptor (sEPCR) is likely a biomarker of cancer-associated hypercoagulability in human hematologic malignancies
por: Ducros, Elodie, et al.
Publicado: (2012)

A novel plasma circular RNA circFARSA is a potential biomarker for non‐small cell lung cancer
por: Hang, Dong, et al.
Publicado: (2018)

Expression of leptin and leptin receptors in colorectal cancer—an immunohistochemical study
por: Al-Shibli, Saad M., et al.
Publicado: (2019)

Leptin receptors
por: Gorska, E, et al.
Publicado: (2010)

BMI trajectories and risk of overall and grade‐specific prostate cancer: An observational cohort study among men seen for prostatic conditions
por: Wang, Kai, et al.
Publicado: (2018)

Metformin reduces prostate cancer risk among men with benign prostatic hyperplasia: A nationwide population‐based cohort study
por: Kuo, Yu‐Jui, et al.
Publicado: (2019)

Long‐term health‐related quality of life among men with prostate cancer in the Finnish randomized study of screening for prostate cancer
por: Talala, Kirsi, et al.
Publicado: (2020)

Transcriptional Characterization of Porcine Leptin and Leptin Receptor Genes
por: Pérez-Montarelo, Dafne, et al.
Publicado: (2013)

Tobacco smoking, polymorphisms in carcinogen metabolism enzyme genes, and risk of localized and advanced prostate cancer: results from the California Collaborative Prostate Cancer Study
por: Shahabi, Ahva, et al.
Publicado: (2014)

Prostate cancer survivors: Risk and mortality in second primary cancers
por: Chattopadhyay, Subhayan, et al.
Publicado: (2018)

Depression and prostate cancer risk: A Mendelian randomization study
por: Chen, Xiong, et al.
Publicado: (2020)

Leptin and leptin receptor gene polymorphisms and their association with plasma leptin levels and obesity in a multi-ethnic Malaysian suburban population
por: Fan, Sook-Ha, et al.
Publicado: (2014)

AST/ALT ratio as a significant predictor of the incidence risk of prostate cancer
por: Zhou, Jiatong, et al.
Publicado: (2020)

Associations between prostate cancer‐related anxiety and health‐related quality of life
por: Erim, Daniel O., et al.
Publicado: (2020)

Prostate cancer risk in patients with melanoma: A systematic review and meta‐analysis
por: Acharya, Prakash, et al.
Publicado: (2020)

Association between PSA values and surveillance quality after prostate cancer surgery
por: Chapman, Christina Hunter, et al.
Publicado: (2019)

Waist circumference and a body shape index and prostate cancer risk and mortality
por: Jochems, Sylvia H. J., et al.
Publicado: (2021)

External beam radiotherapy for prostate cancer: What are the current research trends and hotspots?
por: Li, Rui, et al.
Publicado: (2021)

Strategies for discovery and validation of methylated and hydroxymethylated DNA biomarkers
por: Olkhov-Mitsel, Ekaterina, et al.
Publicado: (2012)

Recent decline in prostate cancer incidence in the United States, by age, stage, and Gleason score
por: Herget, Kimberly A., et al.
Publicado: (2015)

Difference in prostate cancer incidence around sixty years: effects of age and metabolic diseases
por: Choi, Jin Bong, et al.
Publicado: (2018)

Body mass index trajectories and prostate cancer risk: Results from the EPICAP study
por: Lavalette, Céline, et al.
Publicado: (2020)

Race, tumor location, and disease progression among low‐risk prostate cancer patients
por: Mygatt, Justin G., et al.
Publicado: (2020)

Gamma-aminobutyric acid, a potential tumor suppressor for small airway-derived lung adenocarcinoma
por: Schuller, Hildegard M., et al.
Publicado: (2008)

Association between baseline serum glucose, triglycerides and total cholesterol, and prostate cancer risk categories
por: Arthur, Rhonda, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_0dlev5av67pm03q7iimf661nmd